Current products include:

• Pickle juice, typically sold commercially in beverage form. The main active ingredient in this case is vinegar, although the very high sodium content has also been suggested to play a role as an active ingredient. Interestingly, commercial pickle juice beverages have usually never been in contact with a pickle – instead, it is a replica of the pickling brine that is used, including flavouring with dill as occurs when pickling cucumbers.
• Energy gels which contain vinegar or capsicum annum that are marketed specifically for the reduction in cramping.
• A 50 mL commercial “shot” containing a combination of lime juice, capsaicin, ginger and cinnamon.

There are currently no established guidelines or recommendations for the dose of TRP channel agonists required in order to prevent or treat EAMC, nor is the quantity of these components of a product typically labelled. Furthermore, research on pickle juice does not report the specific dose of active ingredients, rather, the total dose of supplement is reported – 1mL/kg of pickle juice.⁴ The 50 mL dose of the commercial shot is listed in research papers as providing up to 38 mg capsicum, up to 500 mg cinnamon, and up to 750 mg ginger.¹